Skip to main navigation Skip to search Skip to main content

Dose vs MPTSCPC: Clinical outcome of varying doses of Micropulse Transscleral Photocoagulation (MP-TSCPC) laser in patients with Glaucoma

Project: Research

Project Details

StatusFinished
Effective start/end date10/3/1906/30/23

Funding

  • Iridex Corporation: $69,658.53